LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 R406
0.37
uM
LJP6
 0.9589 0.0284 0.9403 0.0406
BT-20 Pictilisib
0.37
uM
LJP6
 0.6097 0.0769 0.4388 0.1016
BT-20 Gefitinib
0.37
uM
LJP6
 0.9304 0.0280 0.9003 0.0388
BT-20 Geldanamycin
0.37
uM
LJP5
 0.2888 0.0197 -0.0316 0.0468
BT-20 Geldanamycin
0.37
uM
LJP6
 0.2798 0.0286 -0.0444 0.0527
BT-20 GSK1059615
0.37
uM
LJP5
 0.3819 0.0123 0.1048 0.0104
BT-20 GSK1059615
0.37
uM
LJP6
 0.4551 0.0760 0.2132 0.1014
BT-20 GSK1904529A
0.37
uM
LJP6
 0.9122 0.0116 0.8733 0.0147
BT-20 Omipalisib
0.37
uM
LJP6
 0.2048 0.0226 -0.1519 0.0304
BT-20 GSK 690693
0.37
uM
LJP5
 0.7214 0.0502 0.5980 0.0671
BT-20 GW843682X
0.37
uM
LJP6
 0.5032 0.1109 0.2864 0.1497
BT-20 HG-5-113-01
0.37
uM
LJP5
 0.8400 0.0308 0.7673 0.0461
BT-20 HG-5-88-01
0.37
uM
LJP6
 0.9298 0.0191 0.8986 0.0266
BT-20 Imatinib
0.37
uM
LJP6
 0.9737 0.0101 0.9615 0.0154
BT-20 JNK-9L
0.37
uM
LJP6
 0.6701 0.1182 0.5288 0.1648
BT-20 JW-7-24-1
0.37
uM
LJP6
 0.8382 0.0430 0.7679 0.0583
BT-20 Lapatinib
0.37
uM
LJP6
 0.9514 0.0282 0.9307 0.0394
BT-20 LDN-193189
0.37
uM
LJP5
 0.9421 0.0466 0.9181 0.0656
BT-20 Linifanib
0.37
uM
LJP6
 1.0398 0.0164 1.0581 0.0238
BT-20 Linsitinib
0.37
uM
LJP5
 0.9709 0.0350 0.9591 0.0506
BT-20 Mitoxantrone
0.37
uM
LJP5
 0.2509 0.0342 -0.0870 0.0669
BT-20 Mitoxantrone
0.37
uM
LJP6
 0.2721 0.0212 -0.0556 0.0471
BT-20 MK2206
0.37
uM
LJP6
 0.7322 0.0631 0.6155 0.0848
BT-20 Neratinib
0.37
uM
LJP5
 0.7068 0.0539 0.5769 0.0722
BT-20 Nilotinib
0.37
uM
LJP5
 1.0320 0.0183 1.0472 0.0276